Three goals for the blood disorders community.
NHF provides awards and other fellowships to support research.
2014 gene therapy workshop.
My Life, Our Future aims to reach 5,000 participants in 2015.
Inhibitor Education Summits provide hope.
Shaping up without leaving home.
Teen’s AIDS advocacy endures 30 years after his diagnosis.
More than 1,100 patients from 17 HTCs participated.
New factor IX product may stretch time between infusions.
Understanding their connection to bleeding disorders.
Program launches newly redesigned website.
Hemophilia gene therapy trials start delivering the goods.
NHF spokesperson Alex Borstein found success, levity in comedy.
A Q&A with NIH’s W. Keith Hoots, MD.
Added diagnoses of HIV, hepatitis C can also cause bone loss.
Joining forces in the bleeding disorders community.
It’s an exciting time for bleeding disorders community.
Pilot sites approved and first patients enrolled.
My Life, Our Future aims to unlock hemophilia.
Benefits of genotyping are both individual and communal.